Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ziziphus berry contains bioactive compounds including polyphenols, triterpenic acids, and cyclopeptide alkaloids that demonstrate antioxidant activity with IC50 values of 12.16 μg/ml. These compounds modulate inflammatory pathways by inhibiting TNF-α, IL-6, and IL-1β via NF-κB and JAK1/STAT3/ERK signaling.
Reported Benefits (Provisional)
Origin & History
Ziziphus Berry (Ziziphus jujuba), commonly known as Jujube or Chinese Date, is native to Southern Asia, particularly China, and is now cultivated worldwide across temperate and subtropical regions, including the Middle East and parts of Africa. It thrives in well-drained soils with full sun exposure, valued for its unique flavor and profound medicinal properties.
Research Narrative (Provisional)
Multiple scientific studies, including in vitro, animal, and some human clinical trials, highlight Ziziphus Berry's antioxidant, anti-inflammatory, and sedative effects. Research indicates improvements in sleep latency and quality, digestive health, and immune response, supporting its traditional applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Saponins (jujubosides), flavonoids, and polyphenols, contributing to calming, anti-inflammatory, and adaptogenic effects. - Vitamins: High in Vitamin C, strengthening immune response and offering antioxidant protection. - Minerals: Potassium and magnesium, beneficial for heart health, fluid balance, and muscular function. - Macronutrients: Rich in dietary fiber for digestive health; naturally low in fat.
Reported Mechanism (Provisional)
Ziziphus berry's polyphenols and triterpenic acids exert antioxidant effects by scavenging DPPH radicals and demonstrate anti-inflammatory activity through inhibition of NF-κB pathway signaling. The bioactive compounds suppress pro-inflammatory mediators including nitric oxide, TNF-α, IL-6, and IL-1β while modulating JAK1/STAT3/ERK pathways. Triterpenic acid fractions specifically inhibit macrophage nitric oxide release and splenocyte proliferation at concentrations of 1-100 μg/ml.
Clinical Narrative (Provisional)
Current evidence for Ziziphus berry is primarily limited to in vitro and animal studies, with no published randomized controlled trials providing quantified human clinical outcomes. In vitro studies demonstrate that seven triterpenic compounds inhibit inflammatory cell activation at 1-100 μg/ml concentrations, outperforming other plant fractions in suppressing nitric oxide release and cytokine production. Antioxidant studies show flavonoid content correlates with total antioxidant activity (R²=0.665), but human efficacy data with specific symptom reduction percentages are not available. The lack of clinical trial data limits definitive therapeutic recommendations despite promising preclinical results.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.